The mission of the Electrophysiology Clinical Research & Innovations program (ECRI) at the Texas Heart Institute (THI) is to create and develop an infrastructure for translational and clinical cardiac arrhythmia research and innovation in order to establish Texas Heart Institute as a nationally and internationally recognized leader in the field of cardiac arrhythmias research and management.
The ECRI group is focused on the design and implementation of ongoing research projects targeting detection, management and treatment of cardiac arrhythmias and the development of strategies for community-wide cardiovascular disease education.
Ongoing studies include a variety of research topics with the following goals:
Application of carbon nanotube fibers as a therapeutic and diagnostic tool to manage heart disease
Development of a tool to mitigate esophageal complications during radiofrequency ablation to treat Atrial Fibrillation
Impedance based navigation tool to enable easier access to pericardial space
Wireless pacing to improve cardiac resynchronization therapy
Painless atrial defibrillation modalities to improve a patient’s quality of life
The ECRI group also performs numerous translational and large animal studies to test new drugs, procedures or devices for treatment or prevention of heart rhythm disorders. In addition, ECRI investigators developed the first electrophysiology database at the Texas Heart Institute.
|(From left to right) Joanna Nathan, MEng (alumnus), Brian Greet, MD, David Burkland, MD, Farah Shanoon, MD, Mehdi Razavi, MD, Payam Safavi-Naeini., MD, Mathews John MEng, Anand Ganapathy, MEng |
NCRP Winter 2015 Collaborative Sciences Award, American Heart Association
MacDonald Grant 2010-2011,2013-2017
Private funding from Allergan, Medtronic, Biosense Webster, St. Jude Medical